Analysis of the Off-Licence Use of Recombinant Activated Factor VII for Patients With Uncontrolled Haemorrhage in a UK Tertiary Referral Hospital

Critical Care - United Kingdom
doi 10.1186/cc7596
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy